The antileukemic alkaloid fagaronine and the human K 562 leukemic cells: Effects on growth and induction of erythroid differentiation

This publication has 24 references indexed in Scilit:

• Interaction of the antileukemic alkaloid, 2-hydroxy-3,8,9-trimethoxy-5-methylbenzo[c]phenanthridine (fagaronine), with nucleic acids
  Chemico-Biological Interactions, 1983
• A spectrophotometric method for measuring hemoglobin in erythroleukemic cells (K562).
  Journal of Histochemistry & Cytochemistry, 1981
• A review of the chemistry of the antitumor benzo[c]phenanthridine alkaloids nitidine and fagaronine and of the related antitumor alkaloid coralyne
  Journal of Heterocyclic Chemistry, 1981
• Potential pre‐screening for therapeutic agents that induce differentiation in human myeloid leukemia cells
  International Journal of Cancer, 1980
• BASE SPECIFICITY IN THE INHIBITION OF ONCORNAVIRUS REVERSE TRANSCRIPTASE AND CELLULAR NUCLEIC ACID POLYMERASES BY ANTITUMOR DRUGS *
  Annals of the New York Academy of Sciences, 1977
• Synthesis and biological activity of some antitumor benzophenanthridinium salts
  Journal of Medicinal Chemistry, 1975
• Inhibition of reverse transcriptase activity of RNA-tumor viruses by fagaronine
  Biochemical and Biophysical Research Communications, 1975
• Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome
  Blood, 1975
• Extract of Fagara zanthoxyloides Root in Sickle Cell Anaemia
  Acta Haematologica, 1975
• Fagaronine, a New Tumor Inhibitor Isolated from Fagara zanthoxyloides Lam. (Rutaceae)
  Journal of Pharmaceutical Sciences, 1972